Literature DB >> 27842177

Perspective on Trends in Statin Use.

William S Weintraub1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27842177      PMCID： PMC5621636          DOI： 10.1001/jamacardio.2016.4710

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  15 in total

1.  A tale of coronary artery disease and myocardial infarction.

Authors:  Elizabeth G Nabel; Eugene Braunwald
Journal:  N Engl J Med       Date:  2012-01-05       Impact factor: 91.245

2.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson
Journal:  J Am Coll Cardiol       Date:  2013-11-12       Impact factor: 24.094

Review 3.  Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis.

Authors:  Brian A Ference; Wonsuk Yoo; Issa Alesh; Nitin Mahajan; Karolina K Mirowska; Abhishek Mewada; Joel Kahn; Luis Afonso; Kim Allan Williams; John M Flack
Journal:  J Am Coll Cardiol       Date:  2012-10-17       Impact factor: 24.094

Review 4.  The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice.

Authors:  Naveed A Sattar; Henry Ginsberg; Kausik Ray; M John Chapman; Marcello Arca; Maurizio Averna; D John Betteridge; Deepak Bhatnagar; Elena Bilianou; Rafael Carmena; Richard Ceška; Alberto Corsini; Raimund Erbel; Paul D Flynn; Xavier Garcia-Moll; Janusz Gumprecht; Shun Ishibashi; Selim Jambart; John J P Kastelein; Vincent Maher; Pedro Marques da Silva; Luis Masana; Masato Odawara; Terje R Pedersen; Carlo Maria Rotella; Ibrahim Salti; Tamio Teramoto; Lale Tokgozoglu; Peter P Toth; Paul Valensi; Bruno Vergès
Journal:  Atheroscler Suppl       Date:  2014-06       Impact factor: 3.235

5.  Despite increased use and sales of statins in India, per capita prescription rates remain far below high-income countries.

Authors:  Niteesh K Choudhry; Sagar Dugani; William H Shrank; Jennifer M Polinski; Christina E Stark; Rajeev Gupta; Dorairaj Prabhakaran; Gregory Brill; Prabhat Jha
Journal:  Health Aff (Millwood)       Date:  2014-02       Impact factor: 6.301

6.  Reducing the growing burden of cardiovascular disease in the developing world.

Authors:  Thomas A Gaziano
Journal:  Health Aff (Millwood)       Date:  2007 Jan-Feb       Impact factor: 6.301

7.  Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era.

Authors:  Lawrence D Lazar; Mark J Pletcher; Pamela G Coxson; Kirsten Bibbins-Domingo; Lee Goldman
Journal:  Circulation       Date:  2011-06-27       Impact factor: 29.690

8.  PCSK9 Inhibitors: A Technology Worth Paying For?

Authors:  William S Weintraub; Samuel S Gidding
Journal:  Pharmacoeconomics       Date:  2016-03       Impact factor: 4.981

Review 9.  Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis.

Authors:  Michael G Silverman; Brian A Ference; Kyungah Im; Stephen D Wiviott; Robert P Giugliano; Scott M Grundy; Eugene Braunwald; Marc S Sabatine
Journal:  JAMA       Date:  2016-09-27       Impact factor: 56.272

10.  Trends in Prescription Drug Use Among Adults in the United States From 1999-2012.

Authors:  Elizabeth D Kantor; Colin D Rehm; Jennifer S Haas; Andrew T Chan; Edward L Giovannucci
Journal:  JAMA       Date:  2015-11-03       Impact factor: 56.272
View more
  7 in total

1.  Statin-induced necrotizing autoimmune myopathy.

Authors:  Syed A Huda; Sanjay Yadava; Sara Kahlown; Muhammad S Farooqi; Stephanie Bryant; Ronald Russo
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-10-21

2.  Contemporary Epidemiology of Heart Failure in Fee-For-Service Medicare Beneficiaries Across Healthcare Settings.

Authors:  Rohan Khera; Ambarish Pandey; Colby R Ayers; Vijay Agusala; Sandi L Pruitt; Ethan A Halm; Mark H Drazner; Sandeep R Das; James A de Lemos; Jarett D Berry
Journal:  Circ Heart Fail       Date:  2017-11       Impact factor: 8.790

3.  Immune-Mediated Myopathy in a Patient Presenting for Melanoma Resection and Sentinel Lymph Node Biopsy.

Authors:  Allan R Escher; Jamie P Hoffman; Sarah Alfieri; Bruno Bordoni; Raymond M Evans
Journal:  Cureus       Date:  2022-03-02

4.  Statins induce skeletal muscle atrophy via GGPP depletion-dependent myostatin overexpression in skeletal muscle and brown adipose tissue.

Authors:  Lai Wang; Zu-Guo Zheng; Lingchang Meng; Lijun Zhu; Ping Li; Jun Chen; Hua Yang
Journal:  Cell Biol Toxicol       Date:  2020-10-09       Impact factor: 6.691

5.  Regulation of lactate production through p53/β-enolase axis contributes to statin-associated muscle symptoms.

Authors:  Jiajun Huang; Jingjing Du; Wanjun Lin; Ze Long; Na Zhang; Xiaoming Huang; Ying Xie; Liang Liu; Wenzhe Ma
Journal:  EBioMedicine       Date:  2019-06-11       Impact factor: 8.143

6.  Statin therapy and risk of Alzheimer's and age-related neurodegenerative diseases.

Authors:  Georgina Torrandell-Haro; Gregory L Branigan; Francesca Vitali; Nophar Geifman; Julie M Zissimopoulos; Roberta Diaz Brinton
Journal:  Alzheimers Dement (N Y)       Date:  2020-11-25

7.  The Association Between the Use of Statins and Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis.

Authors:  Chia Siang Kow; Syed Shahzad Hasan
Journal:  Am J Cardiovasc Drugs       Date:  2021-08-03       Impact factor: 3.283
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.